2009
Off-Label Use of Antipsychotic Medications in the Department of Veterans Affairs Health Care System
Leslie DL, Mohamed S, Rosenheck RA. Off-Label Use of Antipsychotic Medications in the Department of Veterans Affairs Health Care System. Psychiatric Services 2009, 60: 1175-1181. PMID: 19723731, DOI: 10.1176/ps.2009.60.9.1175.Peer-Reviewed Original ResearchConceptsAntipsychotic medicationLabel useLogistic regression modelsBipolar disorderVeterans Affairs Health Care SystemVeterans AffairsMultivariate logistic regression modelVA administrative databasesHalf of patientsFirst-generation antipsychoticsOff-label useSevere side effectsMental illness diagnosisPosttraumatic stress disorderHealth care systemClinical characteristicsRegression modelsAntipsychotic useVA patientsAdministrative databasesMinor depressionMajor depressionHigher oddsMedicationsSide effects
2008
Pharmacologic Treatment of Posttraumatic Stress Disorder Among Privately Insured Americans
Harpaz-Rotem I, Rosenheck RA, Mohamed S, Desai RA. Pharmacologic Treatment of Posttraumatic Stress Disorder Among Privately Insured Americans. Psychiatric Services 2008, 59: 1184-1190. PMID: 18832505, DOI: 10.1176/ps.2008.59.10.1184.Peer-Reviewed Original ResearchConceptsPosttraumatic stress disorderPsychotropic medicationsMedication classesStress disorderTreatment of PTSDMental health care usersSymptom-specific responsesComorbid psychiatric disordersUse of anxiolyticsMultivariate logistic regressionDiagnosis of PTSDMajor depressive disorderMental health servicesHealth care usersMedication usePharmacologic treatmentAntidepressant useHealth insurance plansMarketScan databaseAntipsychotic usePrivate health insurance plansPharmacological treatmentDepressive disorderSpecific symptomsMillions of AmericansPharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection.
Mohamed S, Rosenheck RA. Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection. The Journal Of Clinical Psychiatry 2008, 69: 959-65. PMID: 18588361, DOI: 10.4088/jcp.v69n0611.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Anxiety AgentsAntipsychotic AgentsAnxietyComorbidityDrug TherapyFemaleHumansHypnotics and SedativesInternational Classification of DiseasesMaleMiddle AgedPsychotropic DrugsSleep Initiation and Maintenance DisordersStress Disorders, Post-TraumaticUnited StatesUnited States Department of Veterans AffairsConceptsPosttraumatic stress disorderAnxiolytic/Psychotropic medicationsVeterans AffairsMedication classesService usePharmacotherapy of PTSDMental health service useTreatment of PTSDGreater mental health service usePsychotropic medication classesSedative-hypnotic useHealth service useMultivariable logistic regressionAntidepressant useMedication usePsychotropic prescriptionsAntipsychotic useSuch medicationsVA patientsPsychotropic pharmacotherapySymptom responseDepressive disorderVeteran characteristicsSpecific symptoms